Home/ Stocks/ CNSP

CNS Pharmaceuticals, Inc. Common Stock

CNSP XNAS

$3.92 -0.09 (-2.24%) ▼ 15-min delayed

Open

$4.05

High

$4.26

Low

$3.89

Volume

8.4K

Market Cap

$5.73M

About CNS Pharmaceuticals, Inc. Common Stock

CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 8 Website →

Related Market News

No specific coverage for CNSP yet. Check out our latest market news or earnings calendar.

Get CNSP Alerts

Stay ahead with breaking news, price alerts, and expert analysis on CNS Pharmaceuticals, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.